Overview
Compare with Nuburu, Inc., AURA SYSTEMS INC or OZOP ENERGY SOLUTIONS, INC., or pick any stock.
- TickerAETN on OTC1
- IndustryMiscellaneous Electrical Machinery, Equipment & Supplies1
- HeadquartersHillsboro, Oregon1
- Incorporated inDE2
- Business address5291 Ne Elam Young Pkwy, Suite 160, Hillsboro, Or 971242
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
National Electrical Manufacturers Association (“NEMA”) is the association of electrical equipment and medical imaging manufacturers.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product brought in 58% of the revenue AETERNUM HEALTH, INC. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Product | $50.5K | $117.4K |
| Service | $14.6K | $71.4K |
| Power Usage Revenue | $14.9K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs100¢$203.7K
Out of $203.7K in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenue | $203.7K | $65.1K |
| Less revenue share | -$4.4K | -$5.0K |
| Gross margin | $120.1K | -$12.7K |
| Professional fees | $32.7K | $89.3K |
| General and administrative | $105.3K | $99.8K |
| Consulting | $51.4K | $42.0K |
| Officer compensation | $200.0K | $186.7K |
| Total operating expenses | $389.3K | $417.8K |
| Loss from Operations | -$269.3K | -$430.5K |
| Grant income | $50.0K | |
| Interest expense | -$67.8K | -$69.8K |
| Total other expense | -$67.8K | -$19.8K |
| Net loss | -$337.1K | -$450.3K |
| Loss per Common Share: Basic | -$0.01 | -$0.01 |
| Loss per Common Share: Diluted | -$0.01 | -$0.01 |
| Weighted Average Number of Common Shares: Basic | 49.0M shares | 48.5M shares |
| Weighted Average Number of Common Shares: Diluted | 49.0M shares | 48.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $15.4K | $18.3K | |
| Accounts receivable | $984 | ||
| Prepaids | $1.3K | ||
| Inventory | $37.2K | $44.8K | |
| Total Current Assets | $53.6K | $64.4K | |
| Other asset | $1.0K | $1.0K | |
| Total non-current assets | $1.0K | $1.0K | |
| Total Assets | $54.6K | $65.4K | |
| Accounts payable and accrued expenses | $125.0K | $92.4K | |
| Total Current Liabilities | $1.1M | $821.8K | |
| Total Liabilities | $2.1M | $1.7M | |
| Common stock, $0.01 par value, 100,000,000 shares authorized; 49,190,204 and 48,478,678 shares issued and outstanding, respectively | $491.9K | $484.8K | |
| Additional paid-in capital | $809.8K | $802.7K | |
| Accumulated deficit | -$3.3M | -$2.9M | |
| Treasury stock, at cost; 39,975 shares of common stock | -$42.5K | -$42.5K | |
| Total Stockholders Deficit | -$2.0M | -$1.7M | -$1.2M |
| Total Liabilities and Stockholders Deficit | $54.6K | $65.4K | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, shares authorized | 6.9M shares | 6.9M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, shares authorized | 100.0M shares | 100.0M shares | |
| Common stock, shares issued | 49.2M shares | 48.5M shares | |
| Common stock, shares outstanding | 49.2M shares | 48.5M shares | |
| Treasury stock, share | 40.0K shares | 40.0K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $15.4K | $18.3K | |
| Accounts receivable | $984 | ||
| Prepaids | $1.3K | ||
| Inventory | $37.2K | $44.8K | |
| Total Current Assets | $53.6K | $64.4K | |
| Other asset | $1.0K | $1.0K | |
| Total non-current assets | $1.0K | $1.0K | |
| Total Assets | $54.6K | $65.4K | |
| Accounts payable and accrued expenses | $125.0K | $92.4K | |
| Total Current Liabilities | $1.1M | $821.8K | |
| Total Liabilities | $2.1M | $1.7M | |
| Common stock, $0.01 par value, 100,000,000 shares authorized; 49,190,204 and 48,478,678 shares issued and outstanding, respectively | $491.9K | $484.8K | |
| Additional paid-in capital | $809.8K | $802.7K | |
| Accumulated deficit | -$3.3M | -$2.9M | |
| Treasury stock, at cost; 39,975 shares of common stock | -$42.5K | -$42.5K | |
| Total Stockholders Deficit | -$2.0M | -$1.7M | -$1.2M |
| Total Liabilities and Stockholders Deficit | $54.6K | $65.4K | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, shares authorized | 6.9M shares | 6.9M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, shares authorized | 100.0M shares | 100.0M shares | |
| Common stock, shares issued | 49.2M shares | 48.5M shares | |
| Common stock, shares outstanding | 49.2M shares | 48.5M shares | |
| Treasury stock, share | 40.0K shares | 40.0K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$337.1K | -$450.3K |
| Stock compensation | $14.2K | |
| Accounts receivable | -$984 | |
| Inventory | $7.6K | -$37.9K |
| Prepaids | $1.3K | -$1.3K |
| Note receivable | $15.0K | |
| Accounts payable and accrued expenses | $32.7K | $68.9K |
| Accounts payable related party | $11.8K | -$2.9K |
| Accrued interest related party | $67.6K | $67.9K |
| Accrued officer compensation | $200.0K | $186.7K |
| Net cash used by operating activities | -$3.0K | -$154.0K |
| Repayment of related party loan | -$113.2K | |
| Net cash used by financing activities | -$113.2K | |
| Net change in cash | -$3.0K | -$267.3K |
| Interest paid | $2.0K |
No quarter-by-quarter statement was filed.
What it owns
What AETERNUM HEALTH, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Inventory
Leadership
Who has led AETERNUM HEALTH, INC., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerPaul Elliot Mann Jul 15, 2026 to now12
- Chief executive officerJeffrey Kim Apr 5, 2023 to Apr 5, 202313
- PresidentJeffrey Kim Apr 5, 2023 to Apr 5, 202313
Board members and other officers (2)
- Board memberPaul Elliot Mann Jul 15, 2026 to now12
- Board memberJeffrey Kim Apr 5, 2023 to Apr 5, 202313
Former names
Timeline
- Sep 25, 20268-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure14
- Sep 1, 20268-K Executive or director change; Regulation FD disclosure15
- Aug 13, 20268-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure16
- Jul 15, 2026New chief executive Paul Elliot Mann becomes CEO12
- Jul 7, 20268-K Completed an acquisition or sale; Unregistered sale of shares; Change in control17
- Feb 23, 20268-K Completed an acquisition or sale; Unregistered sale of shares; Change in control18
- Jul 15, 20248-K Bylaws or fiscal year changed19
- Apr 5, 2023New chief executive Jeffrey Kim becomes CEO13
- Mar 27, 20238-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares20
- Nov 29, 20228-K Entered a material agreement21
Filings
71 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 8 major events, 4 insider forms, 35 other. The latest 20:
- Sep 25, 20268-K EDGAR
- Sep 1, 2026DEF 14C EDGAR
- Sep 1, 20268-K EDGAR
- Aug 21, 2026PRE 14C EDGAR
- Aug 19, 202610-Q EDGAR
- Aug 14, 2026NT 10-Q EDGAR
- Aug 13, 20268-K EDGAR
- Jul 15, 20263 EDGAR
- Jul 7, 20268-K EDGAR
- May 19, 202610-Q EDGAR
- May 15, 2026NT 10-Q EDGAR
- Mar 31, 202610-K EDGAR
- Mar 9, 2026DEF 14C EDGAR
- Feb 24, 2026PRE 14C EDGAR
- Feb 23, 20268-K EDGAR
- Nov 13, 202510-Q EDGAR
- Sep 3, 202510-K/A EDGAR
- Aug 19, 202510-Q EDGAR
- Aug 13, 2025NT 10-Q EDGAR
- May 20, 202510-Q EDGAR
The 71 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
2 open-market trades by officers, directors and large owners since October 2021: 1 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | EROP Enterprises LLC | Buy | 1,600,000 | $0.06 | $96.0K | Form 4 |
| Feb 11, 2023 | EROP Enterprises LLC | Sale | 2,323,700 | $0.06 | $139.4K | Form 4 |
From Forms 4 filed with the SEC.
SEC filer profile
How AETERNUM HEALTH, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAETERNUM HEALTH, INC.1
- CIK0000764630
- Employer ID (EIN)06-11200723
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company3
- Incorporated inDelaware3
- Fiscal year endsDecember 311
- Industry code (SIC)3690 Miscellaneous Electrical Machinery, Equipment & Supplies1
- SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance1
- Business address5291 Ne Elam Young Pkwy, Suite 160, Hillsboro, OR 971241
- Phone(503) 892-73451
- Shares outstanding97,105,204 as of Aug 19, 202611
- Public float$531.3K as of Jun 30, 20253
- AuditorQI CPA LLC, Valley Stream, New York PCAOB ID 6631; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceMay 30, 20001
- Filings222 in all: 10-Q (54), NT 10-Q (29), 10QSB (23), 10-K (19), NT 10-K (18), 8-K (12), CORRESP (10), UPLOAD (8)1
All 29 form types
10KSB (7), 10QSB/A (6), S-1/A (6), 3 (4), DEF 14C (3), PRE 14C (3), 10-K/A (2), 10-Q/A (2), 10SB12B/A (2), 4 (2), NTN 10Q (2), 10-12B/A (1), 10-QT (1), 10-QT/A (1), 10KSB/A (1), 10SB12B (1), 3/A (1), 8-A12G (1), 8-K/A (1), EFFECT (1), S-1 (1)
- Latest filingsAnnual report (10-K) Mar 31, 2026
Quarterly report (10-Q) Aug 19, 2026
Latest 8-K (8-K) Sep 25, 2026
Risk factors and legal proceedings
Legal proceedings
There are no material claims, actions, suits, proceedings, or investigations that are currently pending or, to the Company’s knowledge, threatened by or against the Company or respecting its operations or assets, or by or against any of the Company’s officers, directors, or affiliates.
The opening of Item 3, Legal Proceedings.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARJeffrey Kim, Chief executive officer
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGARBylaws or fiscal year changed
- 20
- 21SEC EDGAREntered a material agreement